Thus, given SEMA3C’s ability to activate multiple RTK pathways and its key role in prostate cancer growth and survival, it is intriguing to speculate whether SEMA3C might also play an important role in driving angiogenesis, cell growth, cell survival and metastasis in other cancers. The gene discussed is SEMA3C; the disease is Familial prostate cancer.